PillCefdinir
Cefdinir
10 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 16 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it10 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Proficient Rx LP | unknown | 8 | SUPPLYING |
| A-S Medication Solutions | unknown | 7 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 6 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 4 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 4 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 4 | SUPPLYING |
| Direct_Rx | unknown | 4 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 4 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- May 8, 2024RECALLRecall (Class II): Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuti…
Defective container: lack of seal integrity. — Recalling firm: Lupin Pharmaceuticals Inc. — USA Nationwide
- Apr 24, 2024RECALLRecall (Class II): Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin…
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — USA nationwide
- Apr 24, 2024RECALLRecall (Class II): Cefdinir for Oral Suspension USP 125 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin…
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle. — Recalling firm: Lupin Pharmaceuticals Inc. — USA nationwide
- Jul 2, 2020RECALLRecall (Class II): Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Pharmaceutica…
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples. — Recalling firm: Lupin Pharmaceuticals Inc. — U.S.A. Nationwide
- Nov 1, 2019RECALLRecall (Class III): Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Bal…
Presence of Foreign substance: identified as a dead ant. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors/wholesalers throughout the United States.
- Nov 1, 2019RECALLRecall (Class III): Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 681…
Presence of Foreign substance: identified as a dead ant. — Recalling firm: Lupin Pharmaceuticals Inc. — Product was distributed to major distributors/wholesalers throughout the United States.
- May 23, 2019RECALLRecall (Class II): Cefdinir for Oral Suspension USP, 250mg/5mL, Powder for oral suspension, 60 mL bottle, Rx only, Manufactured for: Lupin…
Complaint received of metal piece identified in the product bottle prior to the reconstitution. — Recalling firm: Lupin Pharmaceuticals Inc. — Distributed Nationwide in the USA
- Jan 2, 2019RECALLRecall (Class II): Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-723-20), b)100mL (NDC 68180-723-10), Rx Onl…
CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
- Jan 2, 2019RECALLRecall (Class II): Cefdinir for Oral Suspension USP, 125mg/5mL, packaged in a) 60mL (NDC 68180-722-20), b)100mL (NDC 68180-722-10), Rx Onl…
CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
- Mar 27, 2018RECALLRecall (Class II): Lupin Cefdinir powder for Oral Suspension USP, 250 mg/5 mL in (a) 60 mL packs ( NDC 68180-723-20) and (b) 100 mL packs…
Superpotent Drug — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide
- Feb 26, 2013RECALLRecall (Class II): Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4…
Defective Container: This recall is being carried out due to the potential for improperly sealed bottles. — Recalling firm: Teva Pharmaceuticals USA, Inc. — Nationwide